Fabrice I.
- Country
- France
- Department
- N/A
Research Overview
- Efficacy and Safety of Early In-Hospital Inclisiran Initiation in Patients with Acute Coronary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
- A Randomized, Placebo‑Controlled Trial of Zenagamtide (NNC0487‑0111) in Obese Patients with HFpEF or HFmrEF to Reduce CV Death and HF Hospitalization
- A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk
Data & Insights
Has run more than one trial at 488 of 1214 partner sites.
Specializations
Cardiovascular Disease Management
The investigator specializes in treating various forms of atherosclerotic cardiovascular disease, with particular emphasis on coronary artery disease and its acute manifestations.
- Primary Cardiovascular Risk Management
- Acute Coronary Syndrome Treatment
- Preventive Cardiology
Their work encompasses innovative approaches to reducing major adverse cardiovascular events in high-risk patients.
Heart Failure Research
The investigator focuses on developing therapeutic strategies for heart failure patients, particularly those with reduced left ventricular ejection fraction.
- Novel Heart Failure Therapies
- Biomarker-guided Treatment
- Standard of Care Optimization
Their research includes evaluation of new therapeutic compounds for symptomatic heart failure management.
Interventional Cardiology
The investigator specializes in percutaneous coronary intervention procedures and subsequent therapeutic management, with particular attention to elderly patient populations.
- Antiplatelet Therapy Optimization
- Drug-eluting Stent Procedures
- Age-specific Treatment Strategies
Their work includes developing specialized treatment protocols for patients aged 65 and above undergoing coronary interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.